4.600
−2,13%
2026-10-19
Fundamental Analysis
96 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +139.5% | +158.5% | 3 / 3 | +17.9% | +5.90 pp | +2.93 pp | +20.3% | 0.41 | 1.81 | 161 | +17,9% | 6,3 | +376,7% | 1.81 | 9.59 | −81,1% |
| Pts | 12 | 12 | 12 | 8 | 12 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 4.600 (close price on 2026-10-19)EPS (TTM): 2.542
Financial charts
1.Revenue & growth
VND bn161Q2/26
1.Revenue & growth
VND bn161Q2/26
2.Profit & growth
VND bn6,13Q2/26
3.Profit mix (Penman)
VND bn59,7Q2/26
4.Margins & cost structure
%14.2%Q2/26
5.Returns & cash cycle
% · days21.5%Q2/26
6.Earnings quality & cash
VND bn28,1Q2/26
7.Asset structure
VND bn601Q2/26
8.Funding & debt health
VND bn · times601Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %3,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %179Q2/26
Adjusted EPS growth, latest quarter
126%
Average adjusted EPS growth, 3 quarters
378%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
106%
Source: vnstockData through Q2/26